Graphitic Carbon Nitride/V3O7 Nanocomposites with Antibacterial Property via Photocatalytic and Nanozyme Activities
Source abstract
Abstract
The increasing prevalence of bacterial issues and the misuse of antibiotics have emerged as significant contemporary problems that demand attention. Hence, there is an urgent need for the development of antibiotic-free, efficient, and environmental antibacterial technologies as well as the establishment of an advanced platform for antibiotic detection and analysis. In this study, graphitic carbon nitride/V 3 O 7 nanocomposites (VCNs) with a unique heterojunction structure were synthesized by the chemical precipitation method. VCN not only exhibits remarkably high peroxidase (POD)-like activity but also possesses a favorable band structure. This endows VCN with a broader visible light absorption range and enables effective suppression of the recombination of photogenerated electron–hole pairs, thereby significantly enhancing its photocatalytic activity. With the synergistic effect of photocatalysis and nanozyme catalysis, the “white” plus “black” antibacterial effect of “1 + 1 > 2” has been successfully realized. Therefore, VCN exhibits highly efficient, environmental, and broad-spectrum antibacterial activity (>99.9%). In addition, based on the unique nature of VCN oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB), a colorimetric sensing array was successfully constructed that can extract multichannel information from a single reaction element. The feasibility of this array has been demonstrated in the analysis and detection of tetracycline antibiotics (TCs) within complex environments. This not only provides unique insights into the development of nanomaterials with photocatalytic and nanozyme activities but also offers innovative and sustainable solutions for antibacterial activity and effective monitoring of TCs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Advanced Photocatalysis Techniques · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Key Laboratory of Biomedical Functional Materials, School of Science, China Pharmaceutical University, Nanjing 210009, People’s Republic of China
Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Ministry of Education, Nanjing 210009, People’s Republic of China
Funding
Double First Class University Plan · Jiangsu Innovation and Enterpreneurship Project · National Innovation and Entrepreneurship Training Program for Undergraduate
References (45)
Show source-provided references
1. 10.1038/nature0653610.1038/nature06536 ↗
2. 10.1002/anie.20180497110.1002/anie.201804971 ↗
3. 10.2147/IDR.S17386710.2147/IDR.S173867 ↗
4. 10.1007/s00477-014-0858-710.1007/s00477-014-0858-7 ↗
5. 10.1016/j.cej.2021.12943110.1016/j.cej.2021.129431 ↗
6. 10.1021/accountsmr.1c0007410.1021/accountsmr.1c00074 ↗
7. 10.1039/C7CS00058H10.1039/C7CS00058H ↗
8. 10.1016/j.surfin.2024.10384610.1016/j.surfin.2024.103846 ↗
9. 10.1016/j.trac.2018.05.01210.1016/j.trac.2018.05.012 ↗
10. 10.1039/D0TB02051F10.1039/D0TB02051F ↗
11. 10.1002/adma.20190599410.1002/adma.201905994 ↗
12. 10.1002/adma.20210063710.1002/adma.202100637 ↗
13. 10.1016/j.mtbio.2023.10073010.1016/j.mtbio.2023.100730 ↗
14. 10.1016/j.mattod.2018.05.00110.1016/j.mattod.2018.05.001 ↗
15. 10.1021/acs.analchem.9b0188410.1021/acs.analchem.9b01884 ↗
16. 10.1007/s40843-023-2506-810.1007/s40843-023-2506-8 ↗
17. 10.1016/j.apsusc.2022.15276110.1016/j.apsusc.2022.152761 ↗
18. 10.1016/j.apsusc.2021.15007010.1016/j.apsusc.2021.150070 ↗
19. 10.1016/j.flatc.2023.10059710.1016/j.flatc.2023.100597 ↗
20. 10.1007/s12598-021-01921-y10.1007/s12598-021-01921-y ↗
21. 10.1080/10643389.2023.223912510.1080/10643389.2023.2239125 ↗
22. 10.1016/j.chemosphere.2024.14168610.1016/j.chemosphere.2024.141686 ↗
23. 10.1016/j.talanta.2023.12438710.1016/j.talanta.2023.124387 ↗
24. 10.1016/j.talanta.2023.12514110.1016/j.talanta.2023.125141 ↗
25. 10.1016/j.apcatb.2023.12288210.1016/j.apcatb.2023.122882 ↗
26. 10.1002/anie.20201171110.1002/anie.202011711 ↗
27. 10.1016/j.jallcom.2019.15270710.1016/j.jallcom.2019.152707 ↗
28. 10.1016/j.ceramint.2018.06.19010.1016/j.ceramint.2018.06.190 ↗
29. 10.1016/0169-4332(91)90068-U10.1016/0169-4332(91)90068-U ↗
30. 10.1016/j.talanta.2023.12532410.1016/j.talanta.2023.125324 ↗
31. 10.1002/adfm.20230282410.1002/adfm.202302824 ↗
32. 10.1016/j.jallcom.2010.10.15410.1016/j.jallcom.2010.10.154 ↗
33. 10.1021/jp301511310.1021/jp3015113 ↗
34. 10.1002/adma.20150003310.1002/adma.201500033 ↗
35. 10.1002/cssc.20140316810.1002/cssc.201403168 ↗
36. 10.1016/j.snb.2022.13222910.1016/j.snb.2022.132229 ↗
37. 10.1007/s12038-010-0045-z10.1007/s12038-010-0045-z ↗
38. 10.1016/j.jmst.2023.04.04910.1016/j.jmst.2023.04.049 ↗
39. 10.1007/s10311-022-01526-610.1007/s10311-022-01526-6 ↗
40. 10.1016/j.aca.2023.34170610.1016/j.aca.2023.341706 ↗
41. 10.1021/acsanm.3c0224310.1021/acsanm.3c02243 ↗
42. 10.1016/S0022-0728(97)00305-710.1016/S0022-0728(97)00305-7 ↗
43. 10.1016/S0021-9258(18)34832-410.1016/S0021-9258(18)34832-4 ↗
44. 10.1016/j.bios.2016.12.02810.1016/j.bios.2016.12.028 ↗
45. 10.1109/ACCESS.2019.293365910.1109/ACCESS.2019.2933659 ↗